Intrinsic genetic instability of normal human lymphocytes and its implication for loss of heterozygosity

被引:9
作者
de Nooij-van Dalen, AG
Morolli, B
van der Keur, M
van der Marel, A
Lohman, PHM
Giphart-Gassler, M
机构
[1] Leiden Univ, Med Ctr, MGC, Dept Radiat Genet & Chem Mutagenesis, NL-2300 RA Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Hematol, Leiden, Netherlands
关键词
D O I
10.1002/gcc.1098
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A combination of flow cytometry and microsatellite analysis was used to investigate loss of expression of HLA-A and/or HLA-B alleles and concurrent LOH at polymorphic chromosome 6 loci both in freshly isolated lymphocytes (in vivo mutations) and in lymphocytes cultured ex vivo. The fraction of in vivo mutants that showed LOH at 6p appeared to vary from 0%-49% for various donors. During culturing ex vivo, HLA-A(-) cells arose at a high rate and showed simultaneous loss of expression at the linked HLA-B locus. Up to 90% of the ex vivo arisen HLA-A2(-) cell population showed LOH of multiple 6p markers, and 50% had lost heterozygosity at 6q. This ex vivo spectrum resembles that found in HLA-A2 mutants obtained from lymphoblastoid cells. The HLA-A2 mutants present in vivo may reflect only a small fraction of the mutants that can be detected ex vivo. In normal lymphocytes, in vivo only mitotic recombination appears to be sustained, indicating the importance of this mechanism for tumor initiation in normal cells. Although mutations resulting in LOH at both chromosome 6 arms were shown to result in nonviable cells in normal lymphocytes, they have been shown to result in viable mutants in lymphoblastoid cells. We hypothesize that these types of mutations also occur in vivo bur only survive in cells that already harbor a mutated genetic background. In light of the high rate at which these types of mutations occur, they may contribute to cancer progression. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 34 条
  • [1] MOLECULAR-GENETIC ANALYSIS OF FLOW-SORTED OVARIAN TUMOR-CELLS - IMPROVED DETECTION OF LOSS OF HETEROZYGOSITY
    ABELN, ECA
    CORVER, WE
    KUIPERSDIJKSHOORN, NJ
    FLEUREN, GJ
    CORNELISSE, CJ
    [J]. BRITISH JOURNAL OF CANCER, 1994, 70 (02) : 255 - 262
  • [2] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS
    BARNSTABLE, CJ
    BODMER, WF
    BROWN, G
    GALFRE, G
    MILSTEIN, C
    WILLIAMS, AF
    ZIEGLER, A
    [J]. CELL, 1978, 14 (01) : 9 - 20
  • [3] AN IMPROVED PROCEDURE FOR THE INVITRO EXPANSION OF HUMAN T-LYMPHOCYTE CLONES FOR MUTANT ANALYSIS
    BEARE, DM
    ALDRIDGE, KE
    ODONOVAN, MR
    COLE, J
    [J]. MUTATION RESEARCH, 1993, 291 (03): : 207 - 212
  • [4] Mutations of mitotic checkpoint genes in human cancers
    Cahill, DP
    Lengauer, C
    Yu, J
    Riggins, GJ
    Willson, JKV
    Markowitz, SD
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1998, 392 (6673) : 300 - 303
  • [5] CAVENEE WK, 1983, NATURE, V305, P799
  • [6] CHEN J, 1993, MUTAT RES, V287, P365
  • [7] Both the rate and spectrum of loss of heterozygosity differ between human lymphoblastoid cells derived from various donors
    de Nooij-van Dalen, AG
    Giphart, MJ
    Lohman, PHM
    Giphart-Gassler, M
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 423 (1-2) : 1 - 10
  • [8] de Nooij-van Dalen AG, 1998, GENE CHROMOSOME CANC, V21, P30, DOI 10.1002/(SICI)1098-2264(199801)21:1<30::AID-GCC5>3.0.CO
  • [9] 2-9
  • [10] Isolation and molecular characterization of spontaneous mutants of lymphoblastoid cells with extended loss of heterozygosity
    deNooijvanDalen, AG
    vanBuurenvanSeggelen, VHA
    Mulder, A
    Gelsthorpe, K
    Cole, J
    Lohman, PHM
    GiphartGassler, M
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 374 (01) : 51 - 62